Irregular heartbeat risk much lower in super‑fit people than previously thought | The-14

New research finds super-fit people face a much lower irregular heartbeat risk than believed, while gaining major long-term cardiovascular benefits.

The-14 Pictures

SWANSEA: Morriston Hospital becomes first in Wales to perform pioneering heart procedure using cutting-edge pulse technology

Morriston Hospital’s cardiology team has broken new ground by becoming the first in Wales to treat patients using a revolutionary new technique that destroys malfunctioning heart cells with ultrafast electrical pulses – in a development that could cut waiting times and reduce the risk of complications for thousands of patients with a common heart condition.

The team, led by Consultant Cardiologist and Electrophysiologist Dr Dewi Thomas, successfully treated a patient with Atrial Fibrillation (AF) using a system called Volt Pulsed Field Ablation – a first for Wales and one of the earliest uses of the technology anywhere in the UK.

AF affects around two million people in the UK, causing an irregular and often abnormally fast heart rhythm. Symptoms include fatigue, heart palpitations, breathing difficulties and dizziness – and if left untreated, the condition significantly increases the risk of blood clots, stroke and heart failure.

The Volt system, developed by healthcare company Abbott, uses ultrafast electrical pulses to precisely destroy targeted malfunctioning heart cells. Unlike previous ablation techniques – which used thermal energy to either heat or freeze tissue – the new approach is designed to eliminate the risk of injuring healthy tissue surrounding the heart, representing a significant step forward in both patient safety and procedural efficiency.

Dr Thomas said the procedure had already been performed under general anaesthetic but that future cases could be carried out with patients awake and sedated. “This will result in even shorter procedure times in future, allowing us to treat more patients on an operating list, reducing waiting times for patients and saving money for the health board,” he said.

He described AF as a very common and serious problem, and the Volt system as a powerful new tool. “It won’t completely replace our current approaches to AF ablation, which we’ve been performing very safely and effectively for many years,” he said, “but there are certain patient groups which certainly stand to benefit from this new procedure.”

Dr Thomas added that ablation as a treatment had been refined over more than two decades. “The Volt PFA system represents a milestone in that evolution and we’re really pleased and proud to bring it to Wales, and to be one of the earliest adopters of this technology in the UK.”

The first patient to benefit from the procedure was Glynne Morgan, who lives near Haverfordwest. Mr Morgan had been diagnosed with AF after suffering from chest pains following a bout of flu, and described how his quality of life had deteriorated significantly in the years before his treatment.

Glynne Morgan, from near Haverfordwest, was the first patient in Wales to be treated using the Volt PFA system at Morriston Hospital. Image: Swansea Bay University Health Board

He said he had struggled with breathlessness performing even basic tasks and had been unable to do the outdoor activities – cycling, swimming and running – he had previously enjoyed. “I could sleep most of the day,” he said. “I couldn’t do the sort of outdoor things that I used to do, like gardening or cutting the grass.”

Following the procedure, Mr Morgan praised Dr Thomas and his team unreservedly. “From everything under Dr Thomas right throughout his team to the nurses, it was really exceptional,” he said. “It was very straightforward, no pain, and I hope it becomes the standard format for future heart ablations for other heart sufferers.”

He added: “It’s like a weight has been lifted off my chest. I’ve been so much better. My wife’s been walking the dogs for me because I wasn’t even able to do that – she’s glad I can get back to walking them now!”

Swansea Bay University Health Board said it hoped the new procedure would, in time, reduce waiting lists and deliver savings for the health board, as well as improving outcomes for AF patients across the region.

Related stories from Swansea Bay News

Pontarddulais dad first in Wales to get life-saving new treatment for heart failure
Another Wales-first procedure at Morriston Hospital, giving a local father a new lease of life.

Cardiac service pioneered in Swansea’s Morriston Hospital clocks up 1,000th patient and wins UK recognition
Morriston’s cardiology team reaches a major milestone and earns national acclaim.

Morriston Hospital becomes UK leader for open heart surgery patient safety
The hospital cements its reputation as one of the safest centres for cardiac surgery in the country.

Smaller is better when it comes to affairs of heart monitoring
How miniaturised technology is transforming the way heart conditions are tracked and treated.

Long-serving Swansea NHS healthcare professional signs off with lifetime achievement award
A career dedicated to Swansea Bay patients recognised with a prestigious national honour.

#AtrialFibrillation #cardiology #DrDewiThomas #Haverfordwest #MorristonHospital #SwanseaBayUniversityHealthBoard

Magnetic Fluid in the Heart: A New Frontier in Stroke Prevention.

Magnetic fluid is a new hope in stroke prevention for patients with atrial fibrillation. The technique safely seals the left atrial appendage.

Read more: https://omniletters.com/en/magnetic-fluid-stroke-prevention/

#StrokePrevention #AtrialFibrillation #MagneticFluid #MedicalInnovation #Cardiology #HeartHealth #ScienceNews #MedicalBreakthrough #HealthcareInnovation #BiomedicalEngineering #FutureMedicine #StrokeAwareness #AFib #HeartResearch #ClinicalResearch

Magnetic Fluid in the Heart: A New Frontier in Stroke Prevention

Magnetic fluid is a new hope in stroke prevention for patients with atrial fibrillation. The technique safely seals the left atrial appendage.

Omni Letters

Your Heart’s Warning Signs: A Deep Dive into the 4 Types of Arrhythmias
Are you noticing an irregular heartbeat? Discover the 4 main types of arrhythmias, their warning signs, and how to protect your heart health in our deep dive.
https://www.linkedin.com/pulse/your-hearts-warning-signs-deep-dive-4-types-arrhythmias-arya-jain-slkpc

#HeartHealth #Arrhythmia #Cardiology #HealthyHeart #HeartPalpitations #WellnessTips #AtrialFibrillation #MedicalEducation #HeartAwareness

Coffee Stifles Atrial Fibrillation. DECAF study reveals that those who drank coffee daily show 39% fewer AFib episodes. #AF #atrialfibrillation #coffee #caffeine #arrthymias
https://www.instagram.com/p/DTGzkWGld_k/
Howard G. Smith MD, AM on Instagram: "Coffee Stifles Atrial Fibrillation Conventional wisdom implicates caffeine as a trigger for cardiac arrhythmias. Not so, at least for atrial fibrillation, concludes the so-called DECAF study, an acronym for Does Eliminating Coffee Avoid Fibrillation? Headed by cardiologists from UC-San Francisco and Australia’s University of Adelaide, this clinical trial studied 200 adults with atrial fibrillation. Subjects were randomly assigned to drink at least one cup of caffeinated coffee or avoid caffeine entirely for six months. Those who drank coffee daily show 39% fewer AFib episodes. The investigators suggest multiple reasons for this beneficial effect: caffeine may stimulate increased physical activity, caffeine is a mild diuretic that could lower blood pressure, and coffee contains natural compounds that may reduce inflammation. If this study is confirmed, those with a history of atrial fibrillation, rather than avoiding all caffeinated coffee intake, might benefit from moderate intake of daily “joe.” https://www.sciencedaily.com/releases/2025/11/251110021046.htm https://jamanetwork.com/journals/jama/article-abstract/2841253 #AF #atrialfibrillation #coffee #caffeine #arrthymias"

A groundbreaking study has found that moderate coffee consumption may have a positive impact on atrial fibrillation. Researchers from UC-San Francisco and Australia's University of Adelaide discovered that daily coffee drinkers experienced 39% fewer AFib episodes compared to those who avoided caffeine entirely. The study suggests that caffeine may stimulate physical activity, lower blood pressure, and reduce inflammation, making it a potential beneficial factor in heart health. Could a daily cup of coffee be the key to reducing AFib risk?

Instagram

Good Idea: Drink some Coffee?

https://jamanetwork.com/journals/jama/article-abstract/2841253

A world-first clinical trial found that drinking at least one cup of coffee daily significantly reduced the risk of atrial fibrillation (AF), an irregular heartbeat linked to stroke and heart failure, challenging long-held medical advice to avoid caffeine for heart health. The study, involving 200 adults with AF, showed coffee drinkers had a 39% lower risk of recurrent AF events compared to abstainers, suggesting coffee may be protective rather than harmful. Researchers propose that coffee's benefits may stem from increased physical activity, lower blood pressure, and anti-inflammatory properties. While coffee isn't a cure-all, the findings indicate it can be safely enjoyed by AF patients and may even warrant consideration for non-drinkers.

#HeartHealth #CoffeeBenefits #MedicalResearch #AtrialFibrillation #HealthyHabits

☕️🤔 Ah, the eternal quest for #health enlightenment has led us to this groundbreaking discovery: the #coffee conundrum continues! Apparently, your heart might flutter just as much from the #caffeine #debate as from the coffee itself. Who knew that enabling #JavaScript was the secret ingredient to solving atrial fibrillation? 🙄
https://jamanetwork.com/journals/jama/fullarticle/2841253 #atrialfibrillation #HackerNews #ngated
Caffeinated Coffee Consumption or Abstinence to Reduce Atrial Fibrillation

This clinical trial compares the effect of caffeinated coffee consumption vs abstinence from coffee and caffeine on recurrent atrial fibrillation.

Caffeinated Coffee Consumption or Abstinence to Reduce Atrial Fibrillation

This clinical trial compares the effect of caffeinated coffee consumption vs abstinence from coffee and caffeine on recurrent atrial fibrillation.

☕ A cup of coffee a day could protect against a common heart condition that is a cause of heart failure, stroke and premature death, says #UniofAdelaide

✨Follow the link for more information on this story✨
https://www.scimex.org/newsfeed/cup-of-coffee-reduces-risk-of-irregular-heartbeat

#science #sciencenews #research #stem #facts #knowledge #sciencefacts #coffeelovers #atrialfibrillation

🫀📄 #WorldHeartDay: 'Adjunctive Left Atrial Posterior Wall Isolation in Treating Non-Paroxysmal Atrial Fibrillation: An Updated Meta-Analysis of Randomized Clinical Trials' - a systematic review in the Karger: Cardiovascular System Collection on #ScienceOpen 🔗 https://www.scienceopen.com/document?vid=77109481-17c1-4252-abd3-39d848c039ae

#AtrialFibrillation #CatheterAblation #Electrophysiology #ScienceMastodon

Adjunctive Left Atrial Posterior Wall Isolation in Treating Non-Paroxysmal Atrial Fibrillation: An Updated Meta-Analysis of Randomized Clinical Trials

<p xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" dir="auto" id="d7340757e137"> <b> <i>Background:</i> </b> The clinical outcomes of adjunctive posterior wall isolation (PWI) beyond pulmonary vein isolation (PVI) for non-paroxysmal atrial fibrillation (AF) remain unclear. This meta-analysis was conducted to evaluate the role of PWI in non-paroxysmal AF by pooled analysis of most updated randomized controlled trials (RCTs). <b> <i>Methods:</i> </b> A literature search in PubMed, Embase, and the Cochrane Library was performed to identify RCTs comparing the outcomes of PVI with and without PWI in non-paroxysmal AF patients. The primary outcomes were recurrence rates of all atrial arrhythmias, AF, and atrial tachycardia/flutter (AT/AFL). The secondary outcomes included total procedure time, ablation time, fluoroscopy time and procedure-related complications. Estimated risk ratios (RRs) and 95% confidence intervals (CIs) were evaluated. <b> <i>Results:</i> </b> Nine RCTs with a total of 1,243 non-paroxysmal AF patients were included in our analysis. There were no significant differences in all atrial arrhythmias recurrence (RR: 0.86, 95% CI: 0.66–1.11, <i>p</i> = 0.24, <i>I</i> <sup>2</sup> = 49%) and AF recurrence (RR: 0.74, 95% CI: 0.51–1.08, <i>p</i> = 0.12, <i>I</i> <sup>2</sup> = 62%) between stand-alone PVI group and PVI plus PWI group. Adjunctive PWI increased the AT/AFL recurrence rate (RR: 1.62 95% CI: 1.08–2.42, <i>p</i> = 0.02, <i>I</i> <sup>2</sup> = 0%). In the subgroup analysis, PWI using cryoballoon ablation was associated with a significantly lower recurrence rate of all atrial arrhythmias ( <i>p</i> = 0.01) and AF ( <i>p</i> = 0.02) recurrence and similar recurrence rate of AT/AFL ( <i>p</i> = 0.15). Additional PWI was associated with an increased AT/AFL recurrence ( <i>p</i> = 0.03) in patients with left atrial diameter (LAD) <44 mm. Adjunctive PWI needed longer ablation time, fluoroscopy time, and total procedure time. The incidence of procedural adverse events was low and similar between both groups. <b> <i>Conclusion:</i> </b> Adjunctive PWI beyond PVI did not improve the freedom from all atrial arrhythmias and AF with an increased recurrence rate of AT/AFL in non-paroxysmal AF patients. The ablation energy and LAD might affect the clinical outcome of PWI. However, larger more RCTs were needed to verify our findings. </p>

ScienceOpen